INTRODUCTION {#sec1-1}
============

Amniotic membranes have been used for various purposes in the field of medicine since 100 years. Amniotic membrane comprises amnion and chorion tissues where amnion is thin and chorion is 4 times thicker containing various cytokines and growth factors. Thickness of the chorion is responsible for its higher content of growth factors and cytokine than amnion. According to studies, fresh and dehydrated chorion has greater growth factor and cytokine load compared to fresh and dehydrated amnion.\[[@ref1]\] Thus, chorion membrane may aid in better reduction of inflammation.

Chorion membrane is a well-tolerated, biodegradable membrane. It is widely used since they are bestowed with property of being immune privileged. Its antimicrobial and antibacterial properties are well known. In periodontics, chorion membrane has been used in the treatment of furcation defects, infrabony defects, and gingival soft-tissue coverage.\[[@ref2][@ref3]\] However, to the best of our knowledge, there have been no studies assessing the anti-inflammatory effect of chorion membrane in periodontal therapy.

Thus, the study was aimed to evaluate the anti-inflammatory effect of chorion as a barrier membrane in periodontal pocket therapy by assessing interleukin-11 (IL-11) in gingival crevicular fluid (GCF). IL-11 is an immunoregulatory, pleiotropic cytokine produced by various stromal cells, including fibroblasts, epithelial cells, and osteoblasts which can be detected in GCF.\[[@ref4]\] IL-11 has the potential to downregulate several pro-inflammatory mediators and thereby reducing inflammation. Thus, it is a promising marker of inflammation.\[[@ref5]\] IL-11 can be assessed in GCF which is regarded as the window for analysis of markers of inflammation.

MATERIALS AND METHODS {#sec1-2}
=====================

Patient selection {#sec2-1}
-----------------

A total of 10 patients diagnosed as having severe chronic periodontitis were selected for the study.\[[@ref6]\] The inclusion and exclusion criteria for the study were as follows:

### Inclusion criteria {#sec3-1}

Patients with chronic periodontitis within the age group of 25--45 yearsPatients with at least two teeth on each side of the quadrant probing pocket depth (PPD) of ≥6 mmRadiographic evidence of bone loss.

### Exclusion criteria {#sec3-2}

Patients who had undergone any kind of periodontal treatment during the past 6 monthsPatients on antibiotics or immunosuppressant medication 6 months before the studyChronic smokers, alcoholics, and smokeless tobacco usersPatients with systemic disease that could influence periodontal outcomePregnant and lactating women.

The study was a randomized controlled, single-blind clinical trial with split-mouth design, wherein from each patient, two sites were selected in two quadrants and the sites were randomly divided into test and control groups by flipping a coin.

Group 1 (control) -- Modified flap operationGroup 2 (test) -- Modified flap operation in conjunction with chorion membrane placement.

An informed consent was taken from patients after explaining the procedure in their own language. The ethical clearance was obtained from the Institutional Ethical Committee. The surgical procedure was performed by the single examiner. The chorion membrane was obtained from Tissue Bank of Tata Memorial Hospital, Mumbai, India.

Presurgical procedure {#sec2-2}
---------------------

All the 10 patients received the initial therapy consisting of scaling and root planing. After completion of Phase 1 therapy, the following clinical and biochemical parameters were recorded at baseline and at 4 weeks:

Plaque index (PI)\[[@ref7]\]Sulcus bleeding index (SBI)\[[@ref8]\]PPDClinical attachment level (CAL)IL-11 in GCF.

Collection of gingival crevicular fluid {#sec2-3}
---------------------------------------

The participants were seated comfortably in an upright position in the dental chair. Absorbent cotton rolls and a saliva ejector were used to maintain isolation during the GCF collection. The calibrated microcapillary tube (0--5 μL) was placed extrasulcular, and a standardized volume of 2--3 μL was collected \[[Figure 1](#F1){ref-type="fig"}\]. The microcapillary tubes which were contaminated with blood or inadequate volume of fluid were discarded. After collection of GCF from both the sites, GCF was transferred in sterilized microcentrifuge tubes (Eppendorf tubes) containing 100 μl of phosphate-buffered saline. The samples were stored at −80°C until they were assayed for IL-11. The samples were transported in ice packs to the Department of Clinical Biochemistry, K.L.E. 's Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi, where they were assayed for IL-11with ELISA kit. (Genxbio^®^) \[[Figure 2](#F2){ref-type="fig"}\].

![Collection of gingival crevicular fluid with a microcapillary tube](JISP-22-433-g001){#F1}

![ELISA microplate for interleukin-11](JISP-22-433-g002){#F2}

Periodontal pocket therapy {#sec2-4}
--------------------------

The periodontal pocket therapy was performed with the administration of local anesthesia. Following the incisions, a mucoperiosteal flap was reflected \[Figures [3](#F3){ref-type="fig"} and [4a](#F4){ref-type="fig"}\]. Thorough root planing and degranulation was done using appropriate site-specific curettes. The chorion membrane \[[Figure 4b](#F4){ref-type="fig"}\] was trimmed to appropriate size and adapted over the alveolar bone extending from the base of the flap reflection to the alveolar crest on buccal and lingual aspects \[[Figure 4c](#F4){ref-type="fig"}\]. Flap was repositioned and sutured by interrupted suture technique \[[Figure 4d](#F4){ref-type="fig"}\]. The periodontal dressing was placed. In the Group 1, all surgical procedures were identical except no membrane was placed \[Figure [5a](#F5){ref-type="fig"} and [b](#F5){ref-type="fig"}\]. All patients received postoperative instructions and were prescribed antibiotics and analgesics. The periodontal dressing and sutures were removed 7 days postsurgery. The patients were recalled at 4 weeks to assess clinical and biochemical parameters.\[[@ref9]\]

![Preoperative split-mouth: Group 1 -- 46 and 47; Group 2 -- 16 and 17](JISP-22-433-g003){#F3}

![(a) Full-thickness flap reflected at 16 and 17 in Group 2; (b) chorion membrane; (c) chorion membrane placed at 16 and 17 in Group 2; (d) sutures placed at 16 and 17 in Group 2](JISP-22-433-g004){#F4}

![(a) Full-thickness flap reflected at 46 and 47 in Group 1; (b) sutures placed at 46 and 47 in Group 1](JISP-22-433-g005){#F5}

Statistical analysis {#sec2-5}
--------------------

Wilcoxon signed-rank test was used to assess the significance within each group. Mann--Whitney U-test was applied to analyze the intergroup significance.

RESULTS {#sec1-3}
=======

The baseline clinical parameters in Group 1 and Group 2 are depicted Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Baseline values were similar in both the groups as depicted in [Table 3](#T3){ref-type="table"}. Intragroup comparison revealed statistically significant decrease in all clinical parameters in Group 1 (*P* \< 0.001) and Group 2 (*P* \< 0.001) at 4 weeks \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].

###### 

Intragroup comparison of clinical and biochemical parameters in Group 1

![](JISP-22-433-g006)

###### 

Intragroup comparison of clinical and biochemical parameters in Group 2

![](JISP-22-433-g007)

###### 

Intergroup comparison of clinical and biochemical parameters at baseline

![](JISP-22-433-g008)

Intergroup comparison showed statistically significant decrease in SBI (*P* = 0.004), PPD (*P* = 0.004), and CAL (*P* = 0.013) in Group 2 compared to Group 1 at 4 weeks \[[Table 4](#T4){ref-type="table"}\]. However, PI did not show statistically significant difference on intergroup comparison at 4 weeks (*P* = 0.850).

###### 

Intergroup comparison of clinical and biochemical parameters at 4 weeks

![](JISP-22-433-g009)

Biochemical parameter {#sec2-6}
---------------------

The baseline biochemical parameter in Group 1 and Group 2 is depicted Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Baseline values were similar in both the groups as depicted in [Table 3](#T3){ref-type="table"}. Intragroup comparison showed statistically significant increase in levels of IL-11 in Group 1 (*P* \< 0.001) and Group 2 (*P* \< 0.001) at 4 weeks \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].

Intergroup comparison at baseline showed that IL-11 values were similar for both the groups as shown in [Table 3](#T3){ref-type="table"}. Intergroup comparison at 4 weeks showed statistically significant increase (*P* = 0.006) in IL-11 levels in the Group 2 compared to Group 1 as depicted in [Table 4](#T4){ref-type="table"}.

DISCUSSION {#sec1-4}
==========

The main goal of periodontal treatment is to eliminate inflammatory processes in order to arrest the progression of the disease and keep the dentition in a state of the health. To the best of our knowledge, among various treatment modalities in periodontal treatment, this is the first clinical study assessing the anti-inflammatory effects of chorion membrane on periodontal tissues by assessing IL-11 levels in GCF.

There are studies which have investigated levels of IL-11 in GCF or gingival tissues of the periodontitis patients where it was observed that its levels were decreased in patients with chronic periodontitis.\[[@ref4]\] Yücel *et al*. also reported decreased levels of IL-11 in chronic periodontitis compared to gingivitis or healthy patients.\[[@ref10]\] IL-11 acts as a key mediator in preventing progression of inflammation and induces the osteoblastic differentiation *in vitro* and *in vivo*. This shows that there is a predictive role of IL-11 in periodontitis.

In the present study, after Phase I therapy, in Group 1, the baseline IL-11 value (70.00 ± 6.34) increased to 104.70 ± 9.04 at 4 weeks after flap surgery, suggesting that IL-11 increased with decrease in inflammation \[[Table 1](#T1){ref-type="table"}\]. In Group 2, the baseline value (73.30 ± 5.9) increased to 119.00 ± 8.73 after 4 weeks \[[Table 2](#T2){ref-type="table"}\]. Addition of chorion membrane as an adjunct to flap surgery significantly raised the IL-11 levels in Group 2 compared to Group 1 (*P* = 0.006).

Chorion membrane decreases influx of inflammatory cells to the wound area and consequently reduces inflammatory mediators by serving as a barrier. The chorion tissue contains tissue inhibitors of metalloproteinases which suppress matrix metalloproteinases and transforming growth factor-beta. Two very potent pro-inflammatory mediators, IL-1α and IL-1β, are suppressed by matrix of stroma of chorion tissue.\[[@ref11]\] The chemokines and cytokines can directly affect the T-cells, B-cells, and natural killer cells and thus may modulate inflammation.\[[@ref12]\] Hence, these proteins present in the chorion membrane lead to suppression of inflammation and collagenous degradation.\[[@ref12]\] IL-10 and IL-1 receptor antagonists expressed in chorion tissue suppress the inflammatory process by their own mechanism.\[[@ref13]\]

These mechanisms explain the statistically significant increase in IL-11 and decrease in SBI scores when chorion membrane was used as an adjunct to flap surgery even though the plaque scores in both the groups at 4 weeks did not show statistical significant difference \[[Table 4](#T4){ref-type="table"}\].

The chorion membrane histologically consists of the following layers: reticular, basement membrane, and trophoblasts. This reticular layer of chorion membrane contains collagen Types I, III, IV, V, VI, and VII along with proteoglycans. In basement membrane, collagen Type IV, fibronectins, and laminins are present. Immunohistochemical staining analysis of chorion membranes showed intense concentrations of laminin and laminin-5 throughout the barrier which is of particular importance due to its high affinity for binding gingival epithelial cells for better adaptation to the root surface.\[[@ref14][@ref15]\] These characteristics may have contributed in better PPD reduction and CAL gain in the Group 2 \[[Table 4](#T4){ref-type="table"}\]. Johnson *et al*. reported the decrease in the IL-11 in the periodontal pockets that were deeper than 6 mm and higher in pocket with \<3 mm and healthy tissues.\[[@ref4]\] In the present study, increase in the IL-11 along with PD reduction is in accordance with the study by Johnson *et al*.\[[@ref4]\]

The chorion membrane has numerous advantages owing to its structure and composition. Moreover, the membrane when placed is dry and quickly hydrates with blood, becomes very pliable, and closely adapts to the contours of the underlying alveolar bone. It is self-adherent in nature and does not need to be fixed into place using sutures. It is resorbable, avoiding secondary surgical intervention for its removal.

CONCLUSION {#sec1-5}
==========

Thus, within the limits of our study, it is suggested that adjunctive use of chorion membrane during periodontal pocket therapy provided an additive anti-inflammatory effect along with improvement in clinical outcomes enhancing the long-term prognosis. However, further long-term studies with larger sample size for varied anti-inflammatory markers need to be evaluated.
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